New approaches to invasive fungal infectionsMARR, Kieren A.Current opinion in hematology. 2003, Vol 10, Num 6, pp 445-450, issn 1065-6251, 6 p.Article

Treatment of latrogenic Fungal Infections: A Black Mold Defines a New Gray Zone in MedicineSHOHAM, Shmuel; MARR, Kieren A.Annals of internal medicine. 2013, Vol 158, Num 3, pp 208-210, issn 0003-4819, 3 p.Article

Emerging fungal diseasesNUCCI, Marcio; MARR, Kieren A.Clinical infectious diseases. 2005, Vol 41, Num 4, pp 521-526, issn 1058-4838, 6 p.Article

Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxisBENNETT, John E; IZUMIKAWA, Koichi; MARR, Kieren A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 5, pp 1773-1777, issn 0066-4804, 5 p.Article

New methods to assess susceptibilities of Aspergillus isolates to caspofunginIMHOF, Alexander; ARUNMOZHI BALAJEE, S; MARR, Kieren A et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 12, pp 5683-5688, issn 0095-1137, 6 p.Article

Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipientsBARNES, Penelope D; MARR, Kieren A.British journal of haematology. 2007, Vol 139, Num 4, pp 519-531, issn 0007-1048, 13 p.Article

Design issues in studies evaluating diagnostic tests for aspergillosisMARR, Kieren A; LEISENRING, Wendy.Clinical infectious diseases. 2005, Vol 41, pp S381-S386, issn 1058-4838, SUP6Article

Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantationMARR, Kieren A.Clinical infectious diseases. 2004, Vol 39, pp S170-S175, issn 1058-4838, SUP4Article

Human monocytes differentiate into macrophages under the influence of human KPB-M15 conditioned mediumGERSUK, Geoffrey; HIRAOKA, Atsunobu; MARR, Kieren A et al.Journal of immunological methods. 2005, Vol 299, Num 1-2, pp 99-106, issn 0022-1759, 8 p.Article

Conidial viability assay for rapid susceptibility testing of Aspergillus speciesARUNMOZHI BALAJEE, S; MARR, Kieren A.Journal of clinical microbiology (Print). 2002, Vol 40, Num 8, pp 2741-2745, issn 0095-1137, 5 p.Article

Aspergillus Section Fumigati Typing by PCR-Restriction Fragment PolymorphismSTAAB, Janet F; BALAJEE, S. Arunmozhi; MARR, Kieren A et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 7, pp 2079-2083, issn 0095-1137, 5 p.Article

Differential Aspergillus lentulus Echinocandin Susceptibilities Are Fksp IndependentSTAAB, Janet F; NIELSEN KAHN, Jennifer; MARR, Kieren A et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 4992-4998, issn 0066-4804, 7 p.Article

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassayMARR, Kieren A; LAVERDIERE, Michel; GUGEL, Anja et al.Clinical infectious diseases. 2005, Vol 40, Num 12, pp 1762-1769, issn 1058-4838, 8 p.Article

Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1GERSUK, Geoffrey M; RAZAI, Leon W; MARR, Kieren A et al.Journal of immunological methods. 2008, Vol 329, Num 1-2, pp 157-166, issn 0022-1759, 10 p.Article

Amphotericin B: Time for a new gold standardOSTROSKY-ZEICHNER, Luis; MARR, Kieren A; REX, John H et al.Clinical infectious diseases. 2003, Vol 37, Num 3, pp 415-425, issn 1058-4838, 11 p.Article

Invasive Aspergillosis following Hematopoietic Cell Transplantation : Outcomes and Prognostic Factors Associated with MortalityUPTON, Arlo; KIRBY, Katharine A; CARPENTER, Paul et al.Clinical infectious diseases. 2007, Vol 44, Num 4, pp 531-540, issn 1058-4838, 10 p.Article

Cystic Fibrosis Transmembrane Conductance Regulator Regulates Epithelial Cell Response to Aspergillus and Resultant Pulmonary InflammationCHAUDHARY, Neelkamal; DATTA, Kausik; ASKIN, Frederic B et al.American journal of respiratory and critical care medicine. 2012, Vol 185, Num 3, pp 301-310, issn 1073-449X, 10 p.Article

Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluidMUSHER, Benjamin; FREDRICKS, David; LEISENRING, Wendy et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 12, pp 5517-5522, issn 0095-1137, 6 p.Article

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazoleIMHOF, Alexander; ARUNMOZHI BALAJEE, S; FREDRICKS, David N et al.Clinical infectious diseases. 2004, Vol 39, Num 5, pp 743-746, issn 1058-4838, 4 p.Article

Aspergillus fumigatus variant with decreased susceptibility to multiple antifungalsBALAJEE, S. Arunmozhi; WEAVER, Molly; IMHOF, Alexander et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1197-1203, issn 0066-4804, 7 p.Article

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipientsMARR, Kieren A; CARTER, Rachel A; CRIPPA, Fulvio et al.Clinical infectious diseases. 2002, Vol 34, Num 7, pp 909-917, issn 1058-4838Article

Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients : Biological Risk Factors for Infection According to Time after TransplantationGARCIA-VIDAL, Carol; UPTON, Arlo; KIRBY, Katharine A et al.Clinical infectious diseases. 2008, Vol 47, Num 8, pp 1041-1050, issn 1058-4838, 10 p.Article

Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assayARUNMOZHI BALAJEE, S; IMHOF, Alexander; GRIBSKOVL, Jennifer L et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 1, pp 102-105, issn 0305-7453, 4 p.Article

Mistaken identity : Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatusBALAJEE, S. Arunmozhi; GRIBSKOV, Jennifer; BRANDT, Mary et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 12, pp 5996-5999, issn 0095-1137, 4 p.Article

Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47^phox-/- knockout miceJU, Justina Y; POLHAMUS, Cynthia; MARR, Kieren A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 5, pp 1240-1245, issn 0066-4804Article